Rudolf Carnap : Construction et réduction. Textes inédits sur le physicalisme 1922-1955

Les textes inédits traduits et présentés dans ce volume constituent un témoignage exceptionnel quant à l'évolution de la pensée de Carnap, l'un des fondateurs de la philosophie analytique. Des premières ébauches d'une construction logique du monde à l'analyse logique des propositions du langage, ils nous font en effet assister aux différents moments d'un programme philosophique inscrit dans le débat du physicalisme et de l'unité de la science. La réductibilité des termes de la psychologie puis de la biologie aux termes de la physique implique-t-elle la dérivabilité de leurs lois aux siennes ? Y a-t-il bonne conséquence d'une épistémologie de la réduction à une réduction ontologique ? Le monde, en somme, est-il entièrement explicable par le langage, et si oui, lequel ?

Pharmacokinetics and safety of panobacumab: specific adjunctive immunotherapy in critical patients with nosocomial Pseudomonas aeruginosa O11 pneumonia.

Objectives Nosocomial Pseudomonas aeruginosa pneumonia remains a major concern in critically ill patients. We explored the potential impact of microorganism-targeted adjunctive immunotherapy in such patients. Patients and methods This multicentre, open pilot Phase 2a clinical trial (NCT00851435) prospectively evaluated the safety, pharmacokinetics and potential efficacy of three doses of 1.2 mg/kg panobacumab, a fully human monoclonal anti-lipopolysaccharide IgM, given every 72 h in 18 patients developing nosocomial P. aeruginosa (serotype O11) pneumonia. Results Seventeen out of 18 patients were included in the pharmacokinetic analysis. In 13 patients receiving three doses, the maximal concentration after the third infusion was 33.9 ± 8.0 μg/mL, total area under the serum concentration-time curve was 5397 ± 1993 μg h/mL and elimination half-life was 102.3 ± 47.8 h. Panobacumab was well tolerated, induced no immunogenicity and was detected in respiratory samples. In contrast to Acute Physiology and Chronic Health Evaluation II (APACHE II) prediction, all 13 patients receiving three doses survived, with a mean clinical resolution in 9.0 ± 2.7 days. Two patients suffered a recurrence at days 17 and 20. Conclusions These data suggest that panobacumab is safe, with a pharmacokinetic profile similar to that in healthy volunteers. It was associated with high clinical cure and survival rates in patients developing nosocomial P. aeruginosa O11 pneumonia. We concluded that these promising results warrant further trials.

GABA receptor subunits in human auditory cortex in normal and stroke cases.

GABA receptors are ubiquitous in the cerebral cortex and play a major role in shaping responses of cortical neurons. GABAA and GABAB receptor subunit expression was visualized by immunohistochemistry in human auditory areas from both hemispheres in 9 normal subjects (aged 43-85 years; time between death and fixation 6-24 hours) and in 4 stroke patients (aged 59-87 years; time between death and fixation 7-24 hours) and analyzed qualitatively for GABAA and semiquantitatively for GABAB receptor subunits. In normal brains, the primary auditory area (TC) and the surrounding areas TB and TA displayed distinct GABAA receptor subunit labeling with differences among cortical layers and areas. In postacute and chronic stroke we found a layer-selective downregulation of the alpha-2 subunit in the anatomically intact cerebral cortex of the intact and of the lesioned hemisphere, whereas the alpha-1, alpha-3 and beta-2/3 subunits maintained normal levels of expression. The GABAB receptors had a distinct laminar pattern in auditory areas and minor differences among areas. Unlike in other pathologies, there is no modulation of the GABAB receptor expression in subacute or chronic stroke.

Historicisme absolu et histoire des religions: L'oeuvre de Dario Sabbatucci

Dans ce livre sur les rapports de la foi, de la religion et de la culture, l'auteur - dont Flammarion avait publié un magistral Essai sur le mysticisme grec - et spécialiste de la religion de la Rome antique, très critique envers la phénoménologie religieuse, (Rudolf Otto, Van der Leeuw, Eliade), passe tour à tour en revue « la profession de foi » et les Confessions chrétiennes, la christologie au Concile de Florence, la notion d'« ordre cosmique » dans le domaine indo-iranien, la querelle médiévale des Investitures, le thème du « mandat céleste » en Chine, etc. Toutes les productions magico-religieuses sont ici interprétées comme autant de formations historiques dont il s'agit de retracer les processus d'apparition et de développement ainsi que la fonction culturelle spécifique dans un contexte donné. Mais sont également mis en perspective les pratiques, discours, représentations propres aux savoirs qui étudient ces productions. Une vision des faits religieux qui montre que l'histoire des religions « a problématisé les objets de foi, mais non la foi elle-même », l'abandonnant à la psychologie, à la philosophie ou à l'anthropologie. Or la foi a une histoire, étroitement liée à celle de l'Occident : elle n'est pas, selon l'auteur, une qualité innée chez l'homme, mais relève de circonstances culturelles, non exportables hors de l'Occident. Un essai profondément stimulant...

Zivilgesellschaft, Menschenrechte und Islam

(Résumé de l'ouvrage) Worin bestehen Konfliktpotential und Konvergenzfähigkeit religiöser Minderheiten? Religionen weisen häufig dort Konvergenzen auf, wo ihre Mitglieder einen Lebensraum teilen. Wenn also die Grenzen zwischen den Religionen nicht bereits geographisch festgelegt oder auf andere Weise von vornherein gezogen sind, sondern religiöse Gemeinschaften miteinander Berührungsflächen im Alltag haben, ergibt sich daraus häufig eine kommunikative Dynamik. Sie ist abhängig vom Selbstverständnis der betroffenen Religionsgemeinschaften. Wie wird jüdisches Selbstverständnis durch die jeweilige Umwelt geprägt, insbesondere im Kontakt mit west- und osteuropäischer Kultur? Wie versteht sich das Christentum angesichts einer mehrheitlich nichtchristlichen Umwelt? Wie konkretisiert es sich gegenwärtig in Deutschland in besonderen religiös-kulturellen Ausprägungen und in den Kontexten staatlich regulierter Pluralität? Wie versteht sich der Islam in Abgrenzung gegenüber und in Offenheit für Juden und Christen - vom Rekurs auf die Heilige Schrift her, in der Umsetzung mystischer Religiosität in Organisationen, bei der Konzeption von Bildung? Wie verband und verbindet sich islamisches Selbstverständnis mit europäischen Kulturtraditionen? Was ist hinduistisches Selbstverständnis aus der Perspektive der ,,Unberührbaren" und andererseits aus der Perspektive von Hindus in Deutschland? Wie verbinden sich hinduistisches, tibetisch-buddhistisches und Baha'i-Selbstverständnis mit westeuropäischer Kultur? Verbunden mit welchen Potentialen für Konflikt und Frieden stellt sich das jeweilige Selbstverständnis dar bei afro-amerikanischen Religionen, Hexenreligionen und bei der Rezeption esoterischer Traditionen? Beiträge aus Religionswissenschaft und Theologie, Ethnologie und Orientalistik, Soziologie und Politologie thematisieren Chancen und Probleme der auch in Deutschland zunehmend sich herausbildenden multireligiösen Situation.

In-vitro cell exposure studies for the assessment of nanoparticle toxicity in the lung: a dialog between aerosol science and biology

The introduction of engineered nanostructured materials into a rapidly increasing number of industrial and consumer products will result in enhanced exposure to engineered nanoparticles. Workplace exposure has been identified as the most likely source of uncontrolled inhalation of engineered aerosolized nanoparticles, but release of engineered nanoparticles may occur at any stage of the lifecycle of (consumer) products. The dynamic development of nanomaterials with possibly unknown toxicological effects poses a challenge for the assessment of nanoparticle induced toxicity and safety.In this consensus document from a workshop on in-vitro cell systems for nanoparticle toxicity testing11Workshop on 'In-Vitro Exposure Studies for Toxicity Testing of Engineered Nanoparticles' sponsored by the Association for Aerosol Research (GAeF), 5-6 September 2009, Karlsruhe, Germany. an overview is given of the main issues concerning exposure to airborne nanoparticles, lung physiology, biological mechanisms of (adverse) action, in-vitro cell exposure systems, realistic tissue doses, risk assessment and social aspects of nanotechnology. The workshop participants recognized the large potential of in-vitro cell exposure systems for reliable, high-throughput screening of nanoparticle toxicity. For the investigation of lung toxicity, a strong preference was expressed for air-liquid interface (ALI) cell exposure systems (rather than submerged cell exposure systems) as they more closely resemble in-vivo conditions in the lungs and they allow for unaltered and dosimetrically accurate delivery of aerosolized nanoparticles to the cells. An important aspect, which is frequently overlooked, is the comparison of typically used in-vitro dose levels with realistic in-vivo nanoparticle doses in the lung. If we consider average ambient urban exposure and occupational exposure at 5mg/m3 (maximum level allowed by Occupational Safety and Health Administration (OSHA)) as the boundaries of human exposure, the corresponding upper-limit range of nanoparticle flux delivered to the lung tissue is 3×10-5-5×10-3μg/h/cm2 of lung tissue and 2-300particles/h/(epithelial) cell. This range can be easily matched and even exceeded by almost all currently available cell exposure systems.The consensus statement includes a set of recommendations for conducting in-vitro cell exposure studies with pulmonary cell systems and identifies urgent needs for future development. As these issues are crucial for the introduction of safe nanomaterials into the marketplace and the living environment, they deserve more attention and more interaction between biologists and aerosol scientists. The members of the workshop believe that further advances in in-vitro cell exposure studies would be greatly facilitated by a more active role of the aerosol scientists. The technical know-how for developing and running ALI in-vitro exposure systems is available in the aerosol community and at the same time biologists/toxicologists are required for proper assessment of the biological impact of nanoparticles.

Circulating estrogens and progesterone during primiparous pregnancies and risk of maternal breast cancer.

Pregnancy reduces maternal risk of breast cancer in the long term, but the biological determinants of the protection are unknown. Animal experiments suggest that estrogens and progesterone could be involved, but direct human evidence is scant. A case-control study (536 cases and 1,049 controls) was nested within the Finnish Maternity Cohort. Eligible were primiparous women who delivered at term a singleton offspring before age 40. For each case, two individually matched controls by age (±6 months) and date of sampling (±3 months) were selected. Estradiol, estrone and progesterone in first-trimester serum were measured by high-performance liquid chromatography tandem mass spectrometry and sex-hormone binding globulin (SHBG) by immunoassay. Odds ratios (OR) and 95% confidence intervals (CI) were estimated through conditional logistic regression. In the whole study population there was no association of breast cancer with any of the studied hormones. In analyses stratified by age at diagnosis, however, estradiol concentrations were positively associated with risk of breast cancer before age 40 (upper quartile OR, 1.81; CI, 1.08-3.06), but inversely associated with risk in women who were diagnosed ≥age 40 (upper quartile OR, 0.64; CI, 0.40-1.04), p(interaction) 0.004. Risk estimates for estrone mirrored those for estradiol but were less pronounced. Progesterone was not associated with risk of subsequent breast cancer. Our results provide initial evidence that concentrations of estrogens during the early parts of a primiparous pregnancy are associated with maternal risk of breast cancer and suggest that the effect may differ for tumors diagnosed before and after age 40.